Related Experiment Video
Updated: Feb 7, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Cancer-targeted delivery systems based on peptides
Theodora Chatzisideri1, George Leonidis1, Vasiliki Sarli1
1Department of Chemistry, Aristotle University of Thessaloniki, University Campus, 54124, Thessaloniki, Greece.
Abstract:
There is a growing interest for the discovery of new cancer-targeted delivery systems for drug delivery and diagnosis. A synopsis of the bibliographic data will be presented on bombesin, neurotensin, octreotide, Arg-Gly-Asp, luteinizing hormone-releasing hormone and other peptides. Many of them have reached the clinics for therapeutic or diagnostic purposes, and have been utilized as carriers of known cytotoxic agents such as doxorubicin, paclitaxel, cisplatin, methotrexate or dyes and radioisotopes. In our article, recent advances in the development of peptides as carriers of cytotoxic drugs or radiometals will be analyzed.
Insights
Peptides are emerging as novel cancer-targeted delivery systems for drugs and diagnostics. This review analyzes recent advances in using peptides to carry cytotoxic drugs or radiometals for cancer therapy.
Area of Science:
- Oncology
- Drug Delivery
- Biotechnology
Background:
- Growing interest in novel cancer-targeted delivery systems for improved drug delivery and diagnosis.
- Peptides like bombesin, neurotensin, and octreotide are being explored for their targeting capabilities.
- Existing peptide-based systems are utilized for therapeutic and diagnostic purposes in clinics.
Purpose of the Study:
- To provide a synopsis of bibliographic data on various peptides for cancer targeting.
- To analyze recent advances in the development of peptides as carriers for cytotoxic drugs and radiometals.
- To highlight the clinical applications of peptide-based drug delivery systems.
Main Methods:
- Bibliographic data review and analysis.
- Examination of peptides utilized as carriers for cytotoxic agents (e.g., doxorubicin, paclitaxel) and diagnostic agents (e.g., radioisotopes, dyes).
- Focus on recent developments in peptide-based drug and radiometal delivery systems.
Main Results:
- Several peptides, including bombesin and octreotide, have demonstrated potential in clinical settings.
- Peptides serve as effective carriers for established chemotherapeutic agents and diagnostic payloads.
- Ongoing research focuses on enhancing the efficacy and specificity of peptide-drug conjugates.
Conclusions:
- Peptides represent a promising platform for targeted cancer therapy and diagnosis.
- The development of peptide-based delivery systems is advancing rapidly.
- Further research is warranted to optimize peptide carriers for enhanced therapeutic outcomes.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Peptide Bonds
Second Order systems II
First Order Systems
When a first-order system is subjected to a unit-step input, its response is characterized by its transfer function. By applying the Laplace transform of the unit-step input to the transfer function, expanding the...
Second Order systems I
By reinterpreting the system, one can derive the closed-loop transfer function, which...
Thermodynamic Systems
Consider an example of tea boiling in a kettle. The...

